Annual Cash & Cash Equivalents
$195.81 M
+$93.51 M+91.40%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual cash & cash equivalents is $195.81 million, with the most recent change of +$93.51 million (+91.40%) on December 31, 2023.
- During the last 3 years, OCUL annual cash & cash equivalents has fallen by -$32.25 million (-14.14%).
- OCUL annual cash & cash equivalents is now -14.14% below its all-time high of $228.06 million, reached on December 31, 2020.
Performance
OCUL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$427.22 M
-$32.47 M-7.06%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly cash and cash equivalents is $427.22 million, with the most recent change of -$32.47 million (-7.06%) on September 30, 2024.
- Over the past year, OCUL quarterly cash and cash equivalents has increased by +$316.67 million (+286.45%).
- OCUL quarterly cash and cash equivalents is now -11.53% below its all-time high of $482.89 million, reached on March 31, 2024.
Performance
OCUL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
OCUL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +91.4% | +286.4% |
| 3 y3 years | -14.1% | +138.3% |
| 5 y5 years | +262.2% | +553.1% |
OCUL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.4% | -11.5% | +541.4% |
| 5 y | 5-year | -14.1% | +259.7% | -11.5% | +787.2% |
| alltime | all time | -14.1% | +1018.6% | -11.5% | +3311.5% |
Ocular Therapeutix Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $427.22 M(-7.1%) |
| Jun 2024 | - | $459.69 M(-4.8%) |
| Mar 2024 | - | $482.89 M(+146.6%) |
| Dec 2023 | $195.81 M(+91.4%) | $195.81 M(+77.1%) |
| Sep 2023 | - | $110.55 M(+66.0%) |
| Jun 2023 | - | $66.61 M(-15.7%) |
| Mar 2023 | - | $79.03 M(-22.8%) |
| Dec 2022 | $102.30 M(-37.7%) | $102.30 M(-15.4%) |
| Sep 2022 | - | $120.95 M(-10.1%) |
| Jun 2022 | - | $134.54 M(-7.5%) |
| Mar 2022 | - | $145.42 M(-11.4%) |
| Dec 2021 | $164.16 M(-28.0%) | $164.16 M(-8.4%) |
| Sep 2021 | - | $179.28 M(-6.6%) |
| Jun 2021 | - | $191.86 M(-8.4%) |
| Mar 2021 | - | $209.38 M(-8.2%) |
| Dec 2020 | $228.06 M(+318.9%) | $228.06 M(+222.8%) |
| Sep 2020 | - | $70.64 M(-16.2%) |
| Jun 2020 | - | $84.29 M(+75.1%) |
| Mar 2020 | - | $48.15 M(-11.5%) |
| Dec 2019 | $54.44 M | $54.44 M(-16.8%) |
| Sep 2019 | - | $65.41 M(+5.9%) |
| Jun 2019 | - | $61.77 M(-19.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $76.25 M(+41.0%) |
| Dec 2018 | $54.06 M(+30.2%) | $54.06 M(-4.9%) |
| Sep 2018 | - | $56.86 M(+0.0%) |
| Jun 2018 | - | $56.83 M(-9.7%) |
| Mar 2018 | - | $62.91 M(+51.5%) |
| Dec 2017 | $41.54 M(+26.1%) | $41.54 M(-18.8%) |
| Sep 2017 | - | $51.16 M(-18.8%) |
| Jun 2017 | - | $63.05 M(+15.3%) |
| Mar 2017 | - | $54.68 M(+66.0%) |
| Dec 2016 | $32.94 M(+7.0%) | $32.94 M(-36.9%) |
| Sep 2016 | - | $52.23 M(+8.4%) |
| Jun 2016 | - | $48.17 M(+4.2%) |
| Mar 2016 | - | $46.21 M(+50.1%) |
| Dec 2015 | $30.78 M(-17.7%) | $30.78 M(-25.3%) |
| Sep 2015 | - | $41.20 M(-47.6%) |
| Jun 2015 | - | $78.69 M(+528.3%) |
| Mar 2015 | - | $12.52 M(-66.5%) |
| Dec 2014 | $37.39 M(+113.6%) | $37.39 M(-53.8%) |
| Sep 2014 | - | $80.89 M(+305.6%) |
| Jun 2014 | - | $19.94 M(+56.4%) |
| Mar 2014 | - | $12.75 M(-27.2%) |
| Dec 2013 | $17.50 M(-26.6%) | $17.50 M |
| Dec 2012 | $23.85 M | - |
FAQ
- What is Ocular Therapeutix annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ocular Therapeutix?
- What is Ocular Therapeutix annual cash & cash equivalents year-on-year change?
- What is Ocular Therapeutix quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly cash and cash equivalents year-on-year change?
What is Ocular Therapeutix annual cash & cash equivalents?
The current annual cash & cash equivalents of OCUL is $195.81 M
What is the all time high annual cash & cash equivalents for Ocular Therapeutix?
Ocular Therapeutix all-time high annual cash & cash equivalents is $228.06 M
What is Ocular Therapeutix annual cash & cash equivalents year-on-year change?
Over the past year, OCUL annual cash & cash equivalents has changed by +$93.51 M (+91.40%)
What is Ocular Therapeutix quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OCUL is $427.22 M
What is the all time high quarterly cash and cash equivalents for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly cash and cash equivalents is $482.89 M
What is Ocular Therapeutix quarterly cash and cash equivalents year-on-year change?
Over the past year, OCUL quarterly cash and cash equivalents has changed by +$316.67 M (+286.45%)